| [1] |
Li Tiezheng, Xu Kaikai, Deng Yuqing, Wang Peihao, Qin Qi, Guo Kangshun, Wang Bingren, Chang Dong, Cui Yong.
Analysis of the efficacy and safety of PD-1 inhibitors combined with chemotherapy in neoadjuvant treatment of locally advanced non-small cell lung cancer
[J]. Journal of Capital Medical University, 2024, 45(4): 636-641.
|
| [2] |
Wu Zhaozhen, Zheng Hua, Sheng Shuyan, Zhang Quan, Zhang Hui, Li Jie, Lyu Jialin, Qian Zhe, Wang Shouzheng, Li Xi , Hu Ying.
Observation on the preliminary efficacy of neoadjuvant immunotherapy combined with chemotherapy in non-small cell lung cancer
[J]. Journal of Capital Medical University, 2024, 45(4): 642-648.
|
| [3] |
Xu Yuan, Liang Naixin, Liu Hongsheng.
Prognostic factors in neoadjuvant immunotherapy for non-small cell lung cancer：pathologic lymph node metastasis and primary tumor response
[J]. Journal of Capital Medical University, 2024, 45(4): 649-653.
|
| [4] |
Wang Jusi, Song Weian, Di Shouyin, Liu Junqiang, Fan Boshi, Zhou Shaohua, Yue Caiying, Zhao Jiahua, Chen Siyu, Gong Taiqian.
Efficacy of neoadjuvant chemotherapy combined with immunotherapy in the treatment of stage Ⅲ non-small cell lung cancer
[J]. Journal of Capital Medical University, 2024, 45(4): 660-665.
|
| [5] |
Hao Zhuohong, Yun Duo, Zhang Ying, Li Huihui, Lin Haishan, Cui Yong, Zhao Lei.
Advances in research of perioperative immunotherapy for non-small cell lung cancer—advances in neoadjuvant immunotherapy
[J]. Journal of Capital Medical University, 2024, 45(4): 666-677.
|
| [6] |
Zhao Yue, Ruan Xiangyan, Cheng Jiaojiao, Gu Muqing, Xu Xin, Wang Yuejiao.
Breast cancer pathological diagnosis reveals correlation between progesterone receptor membrane component 1 and clinicopathological parameters
[J]. Journal of Capital Medical University, 2022, 43(3): 350-356.
|
| [7] |
Tan Xiaogang, Zhang Yi.
Progress in neoadjuvant immunotherapy for resectable non-small cell lung cancer
[J]. Journal of Capital Medical University, 2021, 42(5): 862-867.
|
| [8] |
Wang Weiwei, Wang Shanshan, Zhang Man.
Clinical significance of kininogen 1 expression in non-small cell lung cancer biofluids and tissues
[J]. Journal of Capital Medical University, 2021, 42(1): 77-82.
|
| [9] |
Wu Xikang, Wang Yue, He Huiying.
Expression and significance of Slit guidance ligand 3 in upper tract urothelial carcinoma
[J]. Journal of Capital Medical University, 2020, 41(3): 354-359.
|
| [10] |
Wang Lijuan, Ruan Xiangyan, Zhao Yue.
Expression of PGRMC1 in breast cancer tissue and its correlation with clinicopathological features
[J]. Journal of Capital Medical University, 2018, 39(2): 272-276.
|
| [11] |
Hu Mu, Zhang Yi, Xu Qingsheng, Liu Baodong, Su Lei, Wang Ruotian, Zhi Xiuyi.
Clinical study for resection range for early stage non-small cell lung cancer patients
[J]. Journal of Capital Medical University, 2016, 37(6): 763-766.
|
| [12] |
Lin Yunhua, Jiang Yongguang, Fang Wei, Wang Junsheng, Zhou Shaoyou, Sun Xiumei.
Expression of Bmi1 in prostate cancer and its clinical implication
[J]. Journal of Capital Medical University, 2016, 37(3): 323-326.
|
| [13] |
Yao Shuyang, Wang Xin, Li Xiaoxue, Zhang Yi, Zhi Xiuyi.
Pattern of bone metastasis and treatment of Chinese patients with advanced non-small-cell lung cancer
[J]. Journal of Capital Medical University, 2015, 36(4): 533-536.
|
| [14] |
Liu Baodong.
Approaching the igh risk patients with early stage non-small cell lung cancer: Sublobar resection, stereotactic ablative radiotherapy, or radiofrequency ablation？
[J]. Journal of Capital Medical University, 2015, 36(4): 537-543.
|
| [15] |
Liu Shuku, Wang Xiaobin, Li Jie, Cao Xiaoqing, Han Yi, Liu Zhidong.
Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a Meta-analysis
[J]. Journal of Capital Medical University, 2014, 35(6): 705-710.
|
